Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

108.17
+2.051.93%
Post-market: 108.170.00000.00%19:42 EDT
Volume:1.15M
Turnover:124.20M
Market Cap:12.28B
PE:31.98
High:108.49
Open:106.20
Low:105.91
Close:106.12
52wk High:108.49
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.58
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.53
PE(LYR):42.25

Loading ...

Halozyme Director Dannielle Appelhans Files Initial Beneficial Ownership Statement

Reuters
·
Aug 22

Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares

Reuters
·
Aug 20

Halozyme Appoints COUR Pharma CEO Dannielle Appelhans to Board

Reuters
·
Aug 19

Halozyme Appoints Dannielle Appelhans to Its Board of Directors

THOMSON REUTERS
·
Aug 19

Sagtec announces commercial launch of HALO AI Food-Serving Robot

TIPRANKS
·
Aug 18

Movement Alert|Halozyme Therapeutics Rises 5.05% in Regular Trading, Continued Momentum After Q2 Earnings Beat and Analyst Upgrades

Market Focus
·
Aug 18

Halozyme Director Bernadette Connaughton Disposes of 1.626 Shares Worth $167.152,8

Reuters
·
Aug 12

What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation

Simply Wall St.
·
Aug 11

Movement Alert|Halozyme Therapeutics Rises 16.87% in Regular Trading, Q2 Earnings Massively Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 08

Halozyme price target raised to $105 from $93 at Morgan Stanley

TIPRANKS
·
Aug 07

Halozyme Therapeutics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 07

Halozyme Therapeutics, Inc. : Leerink Partners Raises to Outperform from Market Perform; Raises Target Price to $110 from $83

THOMSON REUTERS
·
Aug 07

Halozyme Therapeutics, Inc. : Wells Fargo Raises Target Price to $95 from $75

THOMSON REUTERS
·
Aug 07

Morgan Stanley Adjusts PT on Halozyme Therapeutics to $105 From $93, Maintains Overweight Rating

MT Newswires Live
·
Aug 07

Movement Alert|Halozyme Therapeutics Rises 5.38% in Pre-Market Trading, Q2 Earnings Massively Beat Expectations with Full-Year Guidance Sharply Raised

Market Focus
·
Aug 07

Movement Alert|Halozyme Therapeutics Overnight Rise 6.08%, Q2 Earnings Significantly Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX) and Halozyme (HALO)

TIPRANKS
·
Aug 07

Stock Track | Halozyme Therapeutics Soars 5.39% in After-Hours Trading on Q2 Earnings Beat and Raised Guidance

Stock Track
·
Aug 07

Halozyme Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Halozyme Therapeutics Q2 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

MT Newswires Live
·
Aug 07